Institutional shares held 32.8 Million
8.9K calls
4K puts
Total value of holdings $291M
$78K calls
$35K puts
Market Cap $346M
39,107,800 Shares Out.
Institutional ownership 83.99%
# of Institutions 141


Latest Institutional Activity in ANGO

Top Purchases

Q3 2024
Kent Lake Pr LLC Shares Held: 1M ($8.86M)
Q3 2024
Segall Bryant & Hamill, LLC Shares Held: 911K ($8.08M)
Q3 2024
Millennium Management LLC Shares Held: 2.24M ($19.8M)
Q3 2024
Systematic Financial Management LP Shares Held: 2.41M ($21.4M)
Q3 2024
Dimensional Fund Advisors LP Shares Held: 1.35M ($12M)

Top Sells

Q3 2024
Exodus Point Capital Management, LP Shares Held: 64K ($567K)
Q3 2024
Morgan Stanley Shares Held: 612K ($5.42M)
Q3 2024
Acadian Asset Management LLC Shares Held: 50.6K ($448K)
Q3 2024
Two Sigma Advisers, LP Shares Held: 382K ($3.39M)
Q3 2024
Two Sigma Investments, LP Shares Held: 352K ($3.12M)

About ANGO

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.


Insider Transactions at ANGO

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
517K Shares
From 21 Insiders
Grant, award, or other acquisition 400K shares
Exercise of conversion of derivative security 84.1K shares
Open market or private purchase 32.6K shares
Sell / Disposition
64K Shares
From 5 Insiders
Payment of exercise price or tax liability 64K shares

Track Institutional and Insider Activities on ANGO

Follow ANGIODYNAMICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANGO shares.

Notify only if

Insider Trading

Get notified when an Angiodynamics Inc insider buys or sells ANGO shares.

Notify only if

News

Receive news related to ANGIODYNAMICS INC

Track Activities on ANGO